Nonmyeloablative conditioning with mesenchymal stem cell transplantation for type 1 diabetis mellitus. Background: MUC1, a glycoprotein overexpressed by breast, intestinal, pancreatic, and gastric ...
WALTHAM, Mass.--(BUSINESS WIRE)--Minerva Biotechnologies published “Effective CAR T cell targeting of a MUC1 cleavage product” in the Journal for ImmunoTherapy of ...
MUC1 is a mucin protein overexpressed and abnormally glycosylated in many epithelial cancers. Although it is considered a potential target for vaccine development, its effectiveness is limited by its ...
PRINCETON, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the ...
MUC1 is a membrane-bound glycoprotein that belongs to the mucin family. It is involved in cell adhesion and intracellular signaling. Aberrant expression of MUC1 has been observed in different ...
Multipopulation Analysis of Polymorphisms in Five Mononucleotide Repeats Used to Determine the Microsatellite Instability Status of Human Tumors At a cutoff of 10.2 units/mL, 41 (77%) of 53 pancreatic ...
Researchers from the University of Cape Town's (UCT) Scientific Computing Research Unit (SCRU) have uncovered a critical molecular "switch" that drives the formation of cancer-associated antigens. The ...
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo Company, Ltd (TSE: 4568) announced today that it will pay Glycotope $132.5 million to acquire intellectual property rights of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results